Form 8-K - Current report:
SEC Accession No. 0001558370-21-010404
Filing Date
2021-08-05
Accepted
2021-08-05 08:01:08
Documents
16
Period of Report
2021-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20210730x8k.htm   iXBRL 8-K 68779
2 EX-99.1 glyc-20210730xex99d1.htm EX-99.1 141730
3 EX-99.2 glyc-20210730xex99d2.htm EX-99.2 15388
4 GRAPHIC glyc-20210730xex99d1001.jpg GRAPHIC 4911
5 GRAPHIC glyc-20210730xex99d2001.jpg GRAPHIC 4911
  Complete submission text file 0001558370-21-010404.txt   383430

Data Files

Seq Description Document Type Size
6 EX-101.SCH glyc-20210730.xsd EX-101.SCH 3224
7 EX-101.LAB glyc-20210730_lab.xml EX-101.LAB 15499
8 EX-101.PRE glyc-20210730_pre.xml EX-101.PRE 10518
9 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210730x8k_htm.xml XML 4664
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 211146393
SIC: 2834 Pharmaceutical Preparations